Diethilde Theil

Diethilde Theil is a Senior Principal Scientist and Toxicology Project Leader at Roche, focusing on preclinical safety for small molecule and nucleic acid-based medicines in oncology and neuroscience. They previously served as a Preclinical Safety Assessment Expert at Novartis Institutes for BioMedical Research, as well as in roles including Senior Scientist and Principal Investigator at LMU Klinikum München. Diethilde completed a Dr. med. vet. at Universität Zürich and holds several advanced qualifications in experimental neurology and clinical trial management. Their extensive experience spans over two decades in both academic and industry settings.